AstraZeneca Pharma India Limited — Others, 08-05-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

AstraZeneca Pharma India has confirmed compliance with the dematerialization process for its securities, ensuring that shares converted to electronic form are properly listed on stock exchanges. Physical certificates that were surrendered have been canceled, and the depository is recognized as the registered owner. This enhances seamless electronic trading and custody, improving accuracy and efficiency in shareholder record-keeping and transaction settlement, which benefits investors through smoother trading operations.